Clinical Trial Update: DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigated fasting-mimicking dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Fasting Mimicking Diet, Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED